Replies to post #2820 on BioLineRx Ltd (BLRX)

[midastouch017]

biolinerx GAAP EPS of $0.00 beats by $0.29, revenue of $6.86M beats by $6.52M

May 28, 2024 7:03 AM ETBioLineRx Ltd. (BLRX) Stock

By: Meghavi Singh, SA News Editor

biolinerx press release (NASDAQ:BLRX): Q1 GAAP EPS of $0.00 beats by $0.29.

Revenue of $6.86M beats by $6.52M. The company did not record any revenue during the first quarter of 2023.

As of March 31, 2024, the company had cash, cash equivalents, and short-term bank deposits of $28.2 million.

The company anticipates that this amount will be sufficient to fund operations, as currently planned, into 2025.